| Name | Title | Contact Details |
|---|
Rexton, Inc is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Meridian Healthcare provides high quality care and services to older people in the UK. With care centres spread across the North of England, Meridian cares for over 1400 residents and many more day care clients. In our annual Customer Satisfaction Survey, well over 95% of families are keen to point out that they would recommend us for respite and long term care. We provide nursing, residential and specialist dementia care as well as day care services. Our residents may fund themselves or be funded wholly or partly by their local authorty. Our staff are well trained and undergo a range of mandatory and complementary training programmes ranging from Manual Handling and First Aid through to development programmes for our Managers. We pride ourselves on our training approach which has led to well over 90% of our staff being trained or in the process of training for appropriate NVQ levels.
Biomed Pharmaceuticals is a Sharon Hill, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Magellan Diagnostics is a North Billerica, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Uroplasty is a global medical company committed to offering transformative treatment options through specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Uroplasty’s products include the Urgent® PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Urgent PC is an FDA-cleared system that delivers PTNS (Percutaneous Tibial Nerve Stimulation) and is also indicated for the treatment of fecal incontinence outside the US market. Uroplasty also offers Macroplastique®, an injectable urethral bulking agent for female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Female SUI only in U.S.; male and female SUI outside the U.S. Uroplasty products are typically used when a patient’s treatment goals are not met after conservative and/or drug therapies. Providers and patients alike appreciate that Uroplasty products provide low-risk, effective alternatives to invasive surgery. And because these treatments can be delivered in an office or outpatient setting, the end result is that more patients are given the opportunity to transform their lives with successful treatment.